Studies of E2F and RB-family proteins highlight the importance of these proteins in the regulation of mammalian cell proliferation. While the significance of these proteins is well established, our understanding of what these proteins do, and why their activities are so important, remains vague. At least 119 different cellular proteins have been reported to interact with pRB. E2F is the best known partner of pRB, but it remains uncertain whether E2F is the main target of RB action, one of several targets, or one of a large number of pRB-associated factors that have important roles in different settings. Compounding this problem, the number of proteins linked to pRB in the literature steadily continues to rise. In a similar way, the rapidly growing E2F literature emphasizes that E2F is a complex mix of activities that are subject to many tiers of regulation. Recent studies have shown that E2F is able to induce the expression of a large number of genes that affect a broad cross-section of cellular functions. In order to complement studies of RB and E2F proteins in mammalian cells we have identified and characterized their Drosophila homologs. Our initial experiments show that flies contain both activator and repressor E2Fs, and that the overexpression of dE2F1 is able to drive cell proliferation and induce apoptosis in ways that closely resemble mammalian E2F proteins. One of the major advantages of Drosophila is the opportunity to perform genetic screens. Given that the role of RB and E2F homologs in flies so closely resembles their mammalian counterparts, these screens provide an opportunity to identify, in a relatively unbiased way, those activities that have a significant impact on RB/E2F function in vivo. In this application we propose to screen for mutations that specifically suppress Drosophila phenotypes that have been generated by raising the levels of E2F and RBF. Mutations isolated in this way will be sorted into those that modify E2F-induced phenotypes in multiple settings, and those that are tissue or stage specific. We will test whether the modifiers have a direct effect on transcription, and we will identify modifiers that selectively affect E2F-induced apoptosis. Human homologs will be sought and tested for the ability to act on E2F or pRB in mammalian cells. Since deregulated E2F activity is thought to drive the inappropriate proliferation of many tumor cells, genes that have a strong and conserved impact on pRB and E2F activity will be assessed for mutations in tumor cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA095281-01A1
Application #
6681227
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-09-12
Project End
2007-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Korzelius, Jerome; The, Inge; Ruijtenberg, Suzan et al. (2011) C. elegans MCM-4 is a general DNA replication and checkpoint component with an epidermis-specific requirement for growth and viability. Dev Biol 350:358-69
Stetak, Attila; Hörndli, Frederic; Maricq, Andres V et al. (2009) Neuron-specific regulation of associative learning and memory by MAGI-1 in C. elegans. PLoS One 4:e6019
Boxem, Mike; Maliga, Zoltan; Klitgord, Niels et al. (2008) A protein domain-based interactome network for C. elegans early embryogenesis. Cell 134:534-45
Bell, Daphne W; Brannigan, Brian W; Matsuo, Keitaro et al. (2008) Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms. Clin Cancer Res 14:4079-84
Godin-Heymann, Nadia; Ulkus, Lindsey; Brannigan, Brian W et al. (2008) The T790M ""gatekeeper"" mutation in EGFR mediates resistance to low concentrations of an irreversible EGFR inhibitor. Mol Cancer Ther 7:874-9
Godin-Heymann, Nadia; Bryant, Ianthe; Rivera, Miguel N et al. (2007) Oncogenic activity of epidermal growth factor receptor kinase mutant alleles is enhanced by the T790M drug resistance mutation. Cancer Res 67:7319-26
Pellock, Brett J; Buff, Eugene; White, Kristin et al. (2007) The Drosophila tumor suppressors Expanded and Merlin differentially regulate cell cycle exit, apoptosis, and Wingless signaling. Dev Biol 304:102-15
Di Stefano, Luisa; Ji, Jun-Yuan; Moon, Nam-Sung et al. (2007) Mutation of Drosophila Lsd1 disrupts H3-K4 methylation, resulting in tissue-specific defects during development. Curr Biol 17:808-12
Ceron, Julian; Rual, Jean-Francois; Chandra, Abha et al. (2007) Large-scale RNAi screens identify novel genes that interact with the C. elegans retinoblastoma pathway as well as splicing-related components with synMuv B activity. BMC Dev Biol 7:30
Morris, Erick J; Michaud, William A; Ji, Jun-Yuan et al. (2006) Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo. PLoS Genet 2:e196

Showing the most recent 10 out of 21 publications